Phase 2 Study of EPI-743 for Treatment of Rett Syndrome
Clinical trial NCT01822249 · COMPLETED
Trial details
- NCT number
- NCT01822249
- Sponsor
- Edison Pharmaceuticals Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2013-12-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.